<SEC-DOCUMENT>0000320017-18-000102.txt : 20180802
<SEC-HEADER>0000320017-18-000102.hdr.sgml : 20180802
<ACCEPTANCE-DATETIME>20180802171810
ACCESSION NUMBER:		0000320017-18-000102
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20180802
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180802
DATE AS OF CHANGE:		20180802

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CALADRIUS BIOSCIENCES, INC.
		CENTRAL INDEX KEY:			0000320017
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				222343568
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33650
		FILM NUMBER:		18989521

	BUSINESS ADDRESS:	
		STREET 1:		110 ALLEN ROAD
		STREET 2:		SECOND FLOOR
		CITY:			BASKING RIDGE
		STATE:			NJ
		ZIP:			07920
		BUSINESS PHONE:		908-842-0100

	MAIL ADDRESS:	
		STREET 1:		110 ALLEN ROAD
		STREET 2:		SECOND FLOOR
		CITY:			BASKING RIDGE
		STATE:			NJ
		ZIP:			07920

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Caladrius Biosciences, Inc.
		DATE OF NAME CHANGE:	20150608

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NeoStem, Inc.
		DATE OF NAME CHANGE:	20060906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHASE III MEDICAL INC/DE
		DATE OF NAME CHANGE:	20030819
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8-kaugust2018salesagm.htm
<DESCRIPTION>8-K SALES AGM
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s0d9f31a527384f72ac4b9b8ff8cd0fcf"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date of Report (Date of earliest event reported):&#160;August 2, 2018</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;CALADRIUS BIOSCIENCES, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact Name of Registrant as Specified in Charter)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.40625%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(State or Other Jurisdiction</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">of Incorporation)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">001-33650</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Commission</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">File Number)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22-2343568</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(IRS Employer</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identification No.)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">110 Allen Road, 2nd Floor, Basking Ridge, NJ 07920</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of Principal Executive Offices)(Zip Code)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">(908) 842-0100</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registrant's Telephone Number</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.6015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:3%;"></td><td style="width:97%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.6015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:3%;"></td><td style="width:97%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;&#32;&#32;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.96875%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:3%;"></td><td style="width:97%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.6015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:3%;"></td><td style="width:97%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.6015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:3%;"></td><td style="width:97%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emerging growth company</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.6015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:3%;"></td><td style="width:97%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 230.12b-2 of this chapter).</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.6015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:3%;"></td><td style="width:97%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s857c3616c388457f87c3e54df4854624"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 1.01 Entry into a Material Definitive Agreement.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 2, 2018, Caladrius Biosciences, Inc., a Delaware corporation (the &#8220;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Company</font><font style="font-family:inherit;font-size:10pt;">&#8221;), entered into a First Amendment (the "Amendment") to that certain Common Stock Sales Agreement, dated February 8, 2018 (the "</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Original Agreement</font><font style="font-family:inherit;font-size:10pt;">," and, together with the Amendment, the &#8220;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Sales Agreement</font><font style="font-family:inherit;font-size:10pt;">&#8221;) with H.C. Wainwright &amp; Co., LLC (&#8220;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Wainwright</font><font style="font-family:inherit;font-size:10pt;">&#8221;), as sales agent, in connection with an &#8220;at the market offering&#8221; under which the Company from time to time may offer and sell shares of its common stock, par value $0.001 per share (the &#8220;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Common Stock</font><font style="font-family:inherit;font-size:10pt;">&#8221;), having an aggregate offering price of up to $25,000,000 (the &#8220;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font><font style="font-family:inherit;font-size:10pt;">&#8221;). Shares sold under the Sales Agreement will be offered and sold pursuant to the Company&#8217;s Registration Statement on Form S-3, which was initially filed on July 24, 2018 and which was declared effective by the Securities and Exchange Commission (the "</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SEC</font><font style="font-family:inherit;font-size:10pt;">" on August 2, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;(Registration No. 333-226319) (the &#8220;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Registration Statement</font><font style="font-family:inherit;font-size:10pt;">&#8221;) and a prospectus supplement that the Company expects to file with the SEC relating to the Shares shortly after the filing of this Current Report on Form 8-K. The Amendment updates the Original Agreement to reflect that the Shares will be issued pursuant to the Registration Statement, which replaces the Company's previously effective shelf registration statement.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the Shares, nor shall there be any offer, solicitation or sale of the Shares in any state or country in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or country.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The opinion of the Company&#8217;s counsel regarding the validity of the Shares is filed as Exhibit 5.1 to this Current Report on Form 8-K. This opinion is also filed with reference to, and is hereby incorporated by reference into, the Registration Statement.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company cautions you that statements included in this Current Report on Form 8-K that are not a description of historical facts are forward-looking statements. These forward-looking statements include statements regarding the Company&#8217;s ability to sell Shares pursuant to the Sales Agreement. The inclusion of forward-looking statements should not be regarded as a representation by the Company that any of these statements, results or sales will be achieved or completed due in part to risks and uncertainties inherent in the Company&#8217;s business, including those described in the Company&#8217;s Form 10-K for the year ended December 31, 2017 filed with the SEC on March 22, 2018, as amended on April 2, 2018. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and the Company undertakes no obligation to revise or update this report to reflect events or circumstances after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01 Financial Statements and Exhibits.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.40625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:4%;"></td><td style="width:96%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibits. </font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:95.8984375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:12%;"></td><td style="width:4%;"></td><td style="width:84%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="ex51mintzlegalopinion.htm"><font style="font-family:inherit;font-size:10pt;">5.1</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="ex101amd1toatmsalesagm.htm"><font style="font-family:inherit;font-size:10pt;">10.1</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amendment No. 1 to Common Stock Sales Agreement, dated August 2, 2018, by and between Caladrius Biosciences, Inc. and H.C. Wainwright &amp; Co., LLC. </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="ex51mintzlegalopinion.htm"><font style="font-family:inherit;font-size:10pt;">23.1</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (contained in Exhibit 5.1). </font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s76fc60a9efe049bc96caccf6fa88d1e7"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:13px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.4375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:29%;"></td><td style="width:17%;"></td><td style="width:13%;"></td><td style="width:30%;"></td><td style="width:11%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CALADRIUS BIOSCIENCES, INC.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dated:  August 2, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ David J. Mazzo</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">David J. Mazzo, PhD</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President and Chief Executive Officer</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ex51mintzlegalopinion.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sae60cfdb9db04f99889586d285588f28"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;text-indent:576px;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">Exhibit 5.1</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:666px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:461px;"></td><td style="width:205px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;"><img src="mintzlogo.jpg" alt="mintzlogo.jpg" style="height:37px;width:233px;"></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chrysler Center</font></div><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">666 Third Avenue</font></div><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">New York, NY  10017</font></div><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">212-935-3000</font></div><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">212-983-3115 fax </font></div><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">www.mintz.com</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">August 2, 2018</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Caladrius Biosciences, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110 Allen Road, Second Floor</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basking Ridge, NJ 07920</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ladies and Gentlemen:</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have acted as counsel to Caladrius Biosciences, Inc., a Delaware corporation (the &#8220;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Company</font><font style="font-family:inherit;font-size:10pt;">&#8221;), in connection with the preparation and filing with the Securities and Exchange Commission (the &#8220;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commission</font><font style="font-family:inherit;font-size:10pt;">&#8221;) of a Prospectus Supplement, dated August 2, 2018, to a Prospectus, dated August 2, 2018 (the &#8220;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Prospectus and Prospectus Supplement</font><font style="font-family:inherit;font-size:10pt;">&#8221;), filed pursuant to a Registration Statement on Form S-3, Registration No. 333-226319 (the &#8220;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Registration Statement</font><font style="font-family:inherit;font-size:10pt;">&#8221;), pursuant to which the Company is registering under the Securities Act of 1933, as amended (the &#8220;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Securities Act</font><font style="font-family:inherit;font-size:10pt;">&#8221;), the sale of up to $25,000,000 of shares (the &#8220;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Placement Shares</font><font style="font-family:inherit;font-size:10pt;">&#8221;) of common stock, $0.001 par value per share (the &#8220;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Common Stock</font><font style="font-family:inherit;font-size:10pt;">&#8221;), of the Company. The Placement Shares are being sold pursuant to a Common Stock Sales Agreement, dated as of February 8, 2018, by and between the Company and H.C. Wainwright &amp; Co., LLC, as subsequently amended on August 2, 2018 (as amended, the &#8220;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Agreement</font><font style="font-family:inherit;font-size:10pt;">&#8221;), pursuant to which the Company may issue and sell the Placement Shares pursuant to the Registration Statement and the Prospectus and Prospectus Supplement. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with this opinion, we have examined the Company&#8217;s Amended and Restated Certificate of Incorporation, as amended to date, and Amended and Restated By-laws, as amended to date, such other records of the corporate proceedings of the Company and certificates of the Company&#8217;s officers as we have deemed relevant, as well as the Registration Statement and the exhibits thereto and the Prospectus and the Prospectus Supplement.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In our examination, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, photostatic or facsimile copies and the authenticity of the originals of such copies.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based upon the foregoing, and subject to the limitations set forth below, we are of the opinion that the Placement Shares, when issued by the Company out of the Company&#8217;s duly authorized Common Stock and issued and delivered by the Company against payment therefor as contemplated by the Agreement, on terms approved by the Board of Directors of the Company, or a duly authorized committee thereof, will be duly and validly issued, fully paid and non-assessable.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our opinion is limited to the General Corporation Law of the State of Delaware and the United States federal laws, and we express no opinion with respect to the laws of any other jurisdiction. No opinion is expressed herein with respect to the qualification of the Placement Shares under the securities or blue sky laws of any state or any foreign jurisdiction.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have relied as to certain matters on information obtained from public officials, officers of the Company, and other sources believed by us to be responsible.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Please note that we are opining only as to the matters expressly set forth herein, and no opinion should be inferred as to any other matters. This opinion is based upon currently existing statutes, rules, regulations and judicial decisions, and we disclaim any obligation to advise you of any change in any of these sources of law or subsequent legal or factual developments which might affect any matters or opinions set forth herein.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">August 2, 2018</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Page 2</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We hereby consent to the filing of this opinion as an exhibit to a Current Report on Form 8-K and the Registration Statement in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act and to the use of this Firm&#8217;s name therein and in the Prospectus Supplement under the caption &#8220;Legal Matters.&#8221; In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.4375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:48%;"></td><td style="width:52%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Very truly yours,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:justify;text-indent:384px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ex101amd1toatmsalesagm.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s73f8a6f9d342418caa0e9fb5d9895b6d"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:6px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">Exhibit 10.1</font></div><div style="line-height:120%;padding-bottom:6px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;text-decoration:underline;">AMENDMENT NO. 1 TO COMMON STOCK SALES AGREEMENT</font></div><div style="line-height:120%;padding-bottom:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">August 2, 2018</font></div><div style="line-height:120%;padding-bottom:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Ladies and Gentlemen:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Caladrius Biosciences, Inc. (the &#8220;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Company</font><font style="font-family:inherit;font-size:11pt;">&#8221;) and H.C. Wainwright &amp; Co. LLC (&#8220;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">HCW</font><font style="font-family:inherit;font-size:11pt;">&#8221;) are parties to that certain Common Stock Sales Agreement dated February 8, 2018 (the &#8220;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Original Agreement</font><font style="font-family:inherit;font-size:11pt;">&#8221;). All capitalized terms not defined herein shall have the meanings ascribed to them in the Original Agreement. The parties, intending to be legally bound, hereby amend the Original Agreement as follows: </font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:53px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:42px;">1.</font><font style="font-family:inherit;font-size:11pt;">&#32;&#32;Reference to the &#8220;Registration Statement&#8221; in the Original Agreement shall refer to the registration statement on Form S-3, as amended (File&#160;No. 333-226319), originally filed with the Securities and Exchange Commission on July 24, 2018 (&#8220;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">New Registration Statement</font><font style="font-family:inherit;font-size:11pt;">&#8221;), when the New Registration Statement is declared effective by the Securities and Exchange Commission. </font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">2.</font><font style="font-family:inherit;font-size:11pt;">All references to &#8220;February 8, 2018&#8221; set forth in Schedule 1 and Exhibit 7(m) of the Original Agreement are revised to read &#8220;February 8, 2018 (as amended by Amendment No. 1 to Common Stock Sales Agreement, dated August 2, 2018)&#8221;.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">3.</font><font style="font-family:inherit;font-size:11pt;">Except as specifically set forth herein, all other provisions of the Original Agreement shall remain in full force and effect.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">4.</font><font style="font-family:inherit;font-size:11pt;">This Amendment No. 1 to Common Stock Sales Agreement shall become effective upon the date that the New Registration Statement is declared effective under the Securities Act.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">5.</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Entire Agreement; Amendment; Severability</font><font style="font-family:inherit;font-size:11pt;">. This Amendment No. 1 to the Original Agreement together with the Original Agreement (including all schedules and exhibits attached hereto and thereto and Placement Notices issued pursuant hereto and thereto) constitutes the entire agreement and supersedes all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof. All references in the Original Agreement to the &#8220;Agreement&#8221; shall mean the Original Agreement as amended by this Amendment No. 1; </font><font style="font-family:inherit;font-size:11pt;font-style:italic;">provided, however</font><font style="font-family:inherit;font-size:11pt;">, that all references to &#8220;date of this Agreement&#8221; in the Original Agreement shall continue to refer to the date of the Original Agreement.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">6.</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Applicable Law; Consent to Jurisdiction</font><font style="font-family:inherit;font-size:11pt;">. This amendment shall be governed by, and construed in accordance with, the internal laws of the State of New York without regard to the principles of conflicts of laws. Each party hereby irrevocably submits to the non-exclusive jurisdiction of the state and federal courts sitting in the City of New York, borough of Manhattan, for the adjudication of any dispute hereunder or in connection with any transaction contemplated hereby, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof (certified or registered mail, return receipt requested) to such party at the address in effect for notices to it under this amendment and agrees that such service shall constitute good and sufficient service of process and notice thereof.  Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">7.</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Waiver of Jury Trial</font><font style="font-family:inherit;font-size:11pt;">. The Company and HCW each hereby irrevocably waives any right it may have to a trial by jury in respect of any claim based upon or arising out of this amendment or any transaction contemplated hereby.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:10pt;padding-right:48px;">8.</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Counterparts</font><font style="font-family:inherit;font-size:11pt;">. This amendment may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed amendment by one party to the other may be made by facsimile transmission.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">If the foregoing correctly sets forth the understanding among the Company and HCW, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding amendment to the Original Agreement between the Company and HCW.  </font></div><div style="line-height:120%;text-align:left;padding-left:288px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Very truly yours,</font></div><div style="line-height:120%;text-align:left;padding-left:288px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">CALADRIUS BIOSCIENCES, INC.</font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">_________________________</font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Name:&#160;&#160;&#160;&#160;David J. Mazzo, Ph.D</font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Title:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">President and Chief Executive Officer</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">H.C. WAINWRIGHT &amp; CO. LLC</font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">_________________________</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Name:</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;text-indent:300px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Title: &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:300px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:288px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>mintzlogo.jpg
<TEXT>
begin 644 mintzlogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M_P"#RWX.&ZCMWC\2?V)XJ8%-W[^PLIQ$2 %^8-IL1!);&%/(&T 'ZA?LD?\
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M*NI608@=2 64$]MP]17ZQ_\ !T=_R@H^.?\ W /_ %(-,K\>/^#+;5;?3_\
M@JMXSAFDV27WPOU&" ;2=[C4])D(XZ?*C')P./4B@#^H:OA__@Y#_P"4)7Q\
M_P"P59?^G.SK[@KX?_X.0_\ E"5\?/\ L%67_ISLZ /RA_X,AO\ DZ?XX?\
M8J67_I6:_H^K^<'_ (,AO^3I_CA_V*EE_P"E9K^CZ@#\X/\ @[ _Y0E?$;_L
M*Z)_Z<[>J\G_  2F\#_\%5_^" W[.WP_UW[/H.O6/PO\-ZCX:\0P6<<D^B7S
M:1;,S8(!:&8\31AE\P8.0ZHRV/\ @[ _Y0E?$;_L*Z)_Z<[>OI__ ()._P#*
M++]FG_LE7A?_ --%K0!_+5^R;^TK\<O^#<3_ (*.:A8^(M#U"RNM/ECL/%GA
ME[DQV?B;3M^Y989,%&RNYH+C:VW>PQ\SK7]8O[&_[8?@/]O+]G?P]\4/AOJW
M]K>&/$419/,3R[FRF4[9;:XCR?+FC;*LN2.A4LK*Q^9_^"YG_!%WPI_P5H_9
MWN/LMII^E?&+PK:.WA+Q [>2&.2QL;MPK%[60DXX)B=MZXS(K_SS?\$O/^"E
MWQ;_ .#?W]MK7O#7C+P[KB>'_MHTOQ[X'NW\N92I&+NV!;R_M**0T<F3'-&^
M-VUTD4 _L!K\8?\ @HI_RN!?LB_]D_C_ /1GB2OUJ_9V_:#\)?M6?!#PS\1?
M FK1ZYX1\762W^FWB(T?FQG((9& 9'5@RLC %65@0"#7Y*_\%%/^5P+]D7_L
MG\?_ *,\24 ?L]1110 5_*#_ ,'>/_*9+6O^Q5T?_P!%/7]7U?R@_P#!WC_R
MF2UK_L5='_\ 13T ?TO?\$]?^3!/@=_V3_0?_3=;U[!7C_\ P3U_Y,$^!W_9
M/]!_]-UO7L% !1110 5^-O\ P=5_\%K6_9/^%TG[/7PQUR2U^)GC:R$GB6_L
MI%,GAW2)59?(W8/EW-RN<8(>.'Y_E\V)C]W?\%=_^"H/A?\ X)0_LAZI\0M:
MACU;Q!>N=-\+Z&)0KZOJ#(Q0-R&$$>-\KKDJ@P,LR@_S>_\ !&W_ ()V>+O^
M"\?_  4<UWQ=\3KC6-4\%V>H-XD^(&M;V0WTDKEHM/CDR"C3L"H"$&.&-RN"
MJ"@#[H_X-*O^"*__ "#?VL/B-:_\]X/ 6CW5K_VS?5FW#_KHD.!_>DS_ *LU
M^_U9_A/PIIO@3PKIFAZ-96^FZ/HUI%8V-I FR*U@B0)'&@[*JJ !V K0H **
M** "OS@_X.P/^4)7Q&_["NB?^G.WK]'Z_.#_ (.P/^4)7Q&_["NB?^G.WH _
M*#_@RI_Y2F^/O^R5:C_Z=]'K^GZOY@?^#*G_ )2F^/O^R5:C_P"G?1Z_I^H
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MPP;=YT& .-_[%?&WXP:'^SY\'?%/CKQ-<_8_#W@_2KG6=1E!7<D$$32OMW$
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M&.2>(6<OD)OQ_3=:7<5_:QSP21S03()(Y(V#+(I&001P01SD4 ?C+_P;K?\
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M&U6[XKWO_@W^^(,7Q,_X(T?L^:E#Y92V\+KI1V8QNLIY;-NA/.Z YYZYX7H
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MPA^&WA[PGH<,EOHOA?3+;2-/BDD,C1V]O$L4:ECRQ"(HR>3UK<KY+_X+,_\
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M".<9SP9X^@(YY(XSZ_\ \&8WB:UUC_@E/XFL86_TK2?B+J,4Z$C<-]CI\BL
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M3H=NAD_X1&X=LFXBY+?8I&8Y&,0-QGRV41@'V)_P;K?\IH?^"C__ &4"\_\
M3[K%?L]7\\O_  8_W<M_\7OVCIYY))IIM,T22221BS2,9KXDDGDDGG)K^AJ@
M HHHH *^,_\ @HO_ ,$VOC/^VW\25NO!W[67CSX*>!I-"72[KPSX?T6-FN;G
MS9&DNOMBSQ2@/&T:>7@D>62' 8J/LRB@#\+;O_@R5T6_U^35I_VF/%DVJ37!
MNY+R3PLC7$DQ;>92YN]Q<M\VXG.><YK[>_8Q_P""4W[0'[)WQC\&ZMJG[:_Q
M$^)'@;PVDL&H>$_$'AV*=-7@,3)'']J>Y>2(HQ5]^'8[ H(&:^]** "OAO\
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MQ0_:X\<>-/%-W$ENU]J'A2%FCB3.R*-%N@D<8)8A$55RS'&6)/[/T4 ?G_\
ML??\$D_VA/V0]=\!6EI^VUXX\3^ ?!MW;+<>%M8\&6=S%J.G1*$-BMQ).TT*
MF,!%<%O+ RJYP1^@%%% !5/Q#X>T_P 7:!?:3JUC9ZII>J6\EI>6=W"LUO=P
MR*4DBDC8%71E)4JP(()!&*N44 ?G_P#\$P?^"'6F?\$NOV\?C5X_\%ZSI_\
MPK/XCZ?;P:'X>"2F[T!A,TLL!D<L)(5.!&V[?M;:PRFY_P! *** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
G"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
